UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applications of large language models in cancer care: current evidence and future perspectives

Frontiers in oncology, 2023-09, Vol.13, p.1268915-1268915

2023

Volltextzugriff (PDF)

Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard

Journal of medical Internet research, 2024-05, Vol.26 (5), p.e54758-e54758

2024

Volltextzugriff (PDF)

The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments

Cancers, 2021-08, Vol.13 (16), p.3923

2021

Volltextzugriff (PDF)

Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population

Current oncology reports, 2018-12, Vol.20 (12), p.99-99, Article 99

2018

Volltextzugriff (PDF)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma

Translational oncology, 2022-06, Vol.20, p.101406, Article 101406

2022

Volltextzugriff (PDF)

The challenge of treating older patients with pancreaticobiliary malignancies

Current problems in cancer, 2018-01, Vol.42 (1), p.59-72

2018

Volltextzugriff (PDF)

1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1673-A1673

2023

Volltextzugriff (PDF)

1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1674-A1674

2023

Volltextzugriff (PDF)

Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma

Biomedicines, 2024-04, Vol.12 (4), p.819

2024

Volltextzugriff (PDF)

Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer

Breast care (Basel, Switzerland), 2017-07, Vol.12 (3), p.138-144

2017

Volltextzugriff (PDF)

Vaping and lung cancer – A review of current data and recommendations

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.11-20

2021

Volltextzugriff (PDF)

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

The oncologist (Dayton, Ohio), 2024-05, Vol.29 (5), p.407-414

2024

Volltextzugriff (PDF)

Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS6124-TPS6124

2024

Volltextzugriff (PDF)

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study

The oncologist (Dayton, Ohio), 2024-08

2024

Volltextzugriff (PDF)

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS6116-TPS6116

2023

Volltextzugriff (PDF)

Abstract P3-08-56: The impact of the 21 gene recurrence score (RS) on chemotherapy prescribing in estrogen receptor positive (ER+), lymph node positive (LN+) breast cancer (BC) in Ireland: A national, multi-centre, prospective study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P3-P3-08-56

2020

Volltextzugriff (PDF)

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (9), p.6583-6599

2023

Volltextzugriff (PDF)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (7), p.3753-3774

2023

Volltextzugriff (PDF)

AB052. SOH21AS116. Visceral fat as a tumour promotor: the role of adipose-derived factors in the immune-mediated chemoresistance of oesophageal adenocarcinoma

Mesentery and Peritoneum, 2021-04, Vol.5, p.AB052-AB052

2021

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Applications of large language models in cancer care: current evidence and future perspectives

Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard

The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments

Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma

The challenge of treating older patients with pancreaticobiliary malignancies

1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC)

1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)

Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma

Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer

Vaping and lung cancer – A review of current data and recommendations

Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study

Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study

Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma

Abstract P3-08-56: The impact of the 21 gene recurrence score (RS) on chemotherapy prescribing in estrogen receptor positive (ER+), lymph node positive (LN+) breast cancer (BC) in Ireland: A national, multi-centre, prospective study

Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells

FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy

AB052. SOH21AS116. Visceral fat as a tumour promotor: the role of adipose-derived factors in the immune-mediated chemoresistance of oesophageal adenocarcinoma

Suchergebnisse filtern